Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study.

CONCLUSION: A minority of Taiwanese CHC patients were recommended PEG-IFN/RBV, of which few were willing to receive treatment. PMID: 30448077 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30448077?dopt=Abstract

Source: J Formos Med Assoc - November 15, 2018 Category: General Medicine Authors: Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH Tags: J Formos Med Assoc Source Type: research